At the Early Drug Development Center (EDDC), we work closely and effectively with our partners. To tackle the global cancer challenge and work towards a 21st-century learning health system, we need collaboration.
Our high-quality standards, protocols, and clear agreements enable us to ensure constructive collaborations with CROs and pharmaceutical companies. By working together with several partners, we aim to reach the best results in research activities and clinical trials. Therefore, we are always looking for new collaborations. If you are interested in collaborating with the EDDC, you can have a look at our
focus areas or our
facilities and resources. You can also send an email to
phase1@nki.com. Below, you can find an overview of some our partners: